EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 1990. Start Trial.
Date Value
June 30, 2026 0.1568
March 31, 2026 0.3356
December 31, 2025 0.6868
September 30, 2025 0.5951
June 30, 2025 0.182
March 31, 2025 0.1741
December 31, 2024 0.4505
September 30, 2024 0.6608
June 30, 2024 0.2052
March 31, 2024 0.1524
December 31, 2023 0.401
September 30, 2023 0.5242
June 30, 2023 0.147
March 31, 2023 0.0997
December 31, 2022 0.3008
September 30, 2022 0.3357
June 30, 2022 0.1176
March 31, 2022 0.0562
December 31, 2021 0.2033
September 30, 2021 0.4946
June 30, 2021 -0.0213
March 31, 2021 0.0945
December 31, 2020 0.0926
September 30, 2020 0.3146
June 30, 2020 -0.0823
Date Value
March 31, 2020 0.4029
December 31, 2019 0.3588
September 30, 2019 0.4696
June 30, 2019 0.199
March 31, 2019 0.2962
December 31, 2018 0.7076
September 30, 2018 0.4055
June 30, 2018 0.0322
March 31, 2018 0.1891
December 31, 2017 0.3659
September 30, 2017 0.1913
June 30, 2017 0.1457
March 31, 2017 0.1761
December 31, 2016 0.5088
September 30, 2016 0.2691
June 30, 2016 0.0501
March 31, 2016 0.3981
December 31, 2015 0.8953
September 30, 2015 0.2469
June 30, 2015 0.1292
March 31, 2015 0.1766
December 31, 2014 0.3549
September 30, 2014 0.2321
June 30, 2014 0.0942
March 31, 2014 0.3214

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Medipal Holdings Corp. 0.4183
Vital KSK Holdings, Inc. 0.0467
Cencora, Inc. 3.937
Cardinal Health, Inc. 1.694
McKesson Corp. 5.151